Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 33

1.

Role of Tyrosine Kinase Inhibitors in Indolent and Other Mature B-Cell Neoplasms.

Kutsch N, Marks R, Ratei R, Held TK, Schmidt-Hieber M.

Biomark Insights. 2015 Aug 16;10(Suppl 3):15-23. doi: 10.4137/BMI.S22434. eCollection 2015. Review.

2.

Acquired deficiency of coagulation factor XIII--possible evidence for a new link between coagulation and infection from a case.

Lodemann P, Kolbeck H, Held TK, Ivaskevicius V, Oldenburg J, Schweigerer L, Ludwig WD, Peetz D.

Ann Hematol. 2013 Mar;92(3):427-9. doi: 10.1007/s00277-012-1582-3. Epub 2012 Sep 28. No abstract available.

PMID:
23053180
3.

[Hematopoietic growth factors. Possibilities and limitations].

Held TK, Hildebrandt MO, Ludwig WD.

Internist (Berl). 2010 Jul;51(7):863-71; quiz 872-3. doi: 10.1007/s00108-010-2641-2. German.

PMID:
20544173
4.

Pharmacodynamic effects of haematopoietic cytokines: the view of a clinical oncologist.

Held TK, Gundert-Remy U.

Basic Clin Pharmacol Toxicol. 2010 Mar;106(3):210-4. doi: 10.1111/j.1742-7843.2009.00514.x. Epub 2009 Dec 29. Review.

5.

Immunization with a Pseudomonas aeruginosa 1244 pilin provides O-antigen-specific protection.

Horzempa J, Held TK, Cross AS, Furst D, Qutyan M, Neely AN, Castric P.

Clin Vaccine Immunol. 2008 Apr;15(4):590-7. doi: 10.1128/CVI.00476-07. Epub 2008 Feb 13.

6.

Mycobacterial infection: a difficult and late diagnosis in stem cell transplant recipients.

Cordonnier C, Martino R, Trabasso P, Held TK, Akan H, Ward MS, Fabian K, Ullmann AJ, Wulffraat N, Ljungman P, Alessandrino EP, Pretnar J, Gmür J, Varela R, Vitek A, Sica S, Rovira M; European Blood and Marrow Transplant Group Infectious Diseases Working Party.

Clin Infect Dis. 2004 May 1;38(9):1229-36. Epub 2004 Apr 15.

PMID:
15127333
7.
8.

Reduced-intensity conditioning with busulfan and fludarabine with or without antithymocyte globulin in HLA-identical sibling transplantation--a retrospective analysis.

Schetelig J, Bornhäuser M, Kiehl M, Schwerdtfeger R, Kröger N, Runde V, Zabelina T, Held TK, Thiede C, Fauser AA, Beelen D, Zander A, Ehninger G, Siegert W; Cooperative German Transplant Study Group.

Bone Marrow Transplant. 2004 Mar;33(5):483-90.

PMID:
14716342
9.

Cytomegalovirus infections in allogeneic stem cell recipients after reduced-intensity or myeloablative conditioning assessed by quantitative PCR and pp65-antigenemia.

Schetelig J, Oswald O, Steuer N, Radonic A, Thulke S, Held TK, Oertel J, Nitsche A, Siegert W.

Bone Marrow Transplant. 2003 Oct;32(7):695-701.

PMID:
13130317
10.

Evidence of a graft-versus-leukemia effect in chronic lymphocytic leukemia after reduced-intensity conditioning and allogeneic stem-cell transplantation: the Cooperative German Transplant Study Group.

Schetelig J, Thiede C, Bornhauser M, Schwerdtfeger R, Kiehl M, Beyer J, Sayer HG, Kroger N, Hensel M, Scheffold C, Held TK, Hoffken K, Ho AD, Kienast J, Neubauer A, Zander AR, Fauser AA, Ehninger G, Siegert W; Cooperative German Transplant Study Group.

J Clin Oncol. 2003 Jul 15;21(14):2747-53.

PMID:
12860954
11.

Outcome analysis of 189 consecutive cancer patients referred to the intensive care unit as emergencies during a 2-year period.

Maschmeyer G, Bertschat FL, Moesta KT, Häusler E, Held TK, Nolte M, Osterziel KJ, Papstein V, Peters M, Reich G, Schmutzler M, Sezer O, Stula M, Wauer H, Wörtz T, Wischnewsky M, Hohenberger P.

Eur J Cancer. 2003 Apr;39(6):783-92.

PMID:
12651204
12.

K-antigen-specific, but not O-antigen-specific natural human serum antibodies promote phagocytosis of Klebsiella pneumoniae.

Lepper PM, Möricke A, Held TK, Schneider EM, Trautmann M.

FEMS Immunol Med Microbiol. 2003 Mar 20;35(2):93-8.

13.

Recruitment of murine neutrophils in vivo through endogenous sialidase activity.

Cross AS, Sakarya S, Rifat S, Held TK, Drysdale BE, Grange PA, Cassels FJ, Wang LX, Stamatos N, Farese A, Casey D, Powell J, Bhattacharjee AK, Kleinberg M, Goldblum SE.

J Biol Chem. 2003 Feb 7;278(6):4112-20. Epub 2002 Nov 22.

14.

Kinetics of stem cell engraftment and clearance of leukaemia cells after allogeneic stem cell transplantation with reduced intensity conditioning in chronic myeloid leukaemia.

Kreuzer KA, Schmidt CA, Schetelig J, Held TK, Thiede C, Ehninger G, Siegert W.

Eur J Haematol. 2002 Jul;69(1):7-10.

PMID:
12270056
15.

Clinical implications of antibiotic-induced endotoxin release in septic shock.

Lepper PM, Held TK, Schneider EM, Bölke E, Gerlach H, Trautmann M.

Intensive Care Med. 2002 Jul;28(7):824-33. Epub 2002 May 30. Review.

PMID:
12122518
16.

Allogeneic transplantation after reduced conditioning in high risk patients is complicated by a high incidence of acute and chronic graft-versus-host disease.

Schetelig J, Kröger N, Held TK, Thiede C, Krusch A, Zabelina T, Dubiel M, Rick O, Bornhäuser M, Ehninger G, Zander AR, Siegert W.

Haematologica. 2002 Mar;87(3):299-305.

17.

Quality control for the diagnosis of Toxoplasma gondii reactivation in SCT patients using PCR assays.

Costa JM, Munoz C, Krüger D, Martino R, Held TK, Dardé ML, Cordonnier C, Bretagne S; Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation.

Bone Marrow Transplant. 2001 Sep;28(5):527-8. No abstract available.

18.

Quantitative detection of Toxoplasma gondii DNA in human body fluids by TaqMan polymerase chain reaction.

Kupferschmidt O, Krüger D, Held TK, Ellerbrok H, Siegert W, Janitschke K.

Clin Microbiol Infect. 2001 Mar;7(3):120-4.

19.

Rapid quantification and differentiation of human polyomavirus DNA in undiluted urine from patients after bone marrow transplantation.

Biel SS, Held TK, Landt O, Niedrig M, Gelderblom HR, Siegert W, Nitsche A.

J Clin Microbiol. 2000 Oct;38(10):3689-95.

20.

Treatment of BK virus-associated hemorrhagic cystitis and simultaneous CMV reactivation with cidofovir.

Held TK, Biel SS, Nitsche A, Kurth A, Chen S, Gelderblom HR, Siegert W.

Bone Marrow Transplant. 2000 Aug;26(3):347-50.

21.

Diagnosis of toxoplasmosis in bone marrow transplant recipients: comparison of PCR-based results and immunohistochemistry.

Held TK, Krüger D, Switala AR, Beyer J, Kingreen D, Busemann C, Janitschke K, Siegert W.

Bone Marrow Transplant. 2000 Jun;25(12):1257-62.

23.

Role of hematopoietic growth factors in non-neutropenic infections and sepsis.

Held TK, Cross AS.

Curr Opin Hematol. 1999 May;6(3):176-83. Review.

PMID:
10226739
25.
26.
27.

O-antigen seroepidemiology of Klebsiella clinical isolates and implications for immunoprophylaxis of Klebsiella infections.

Trautmann M, Ruhnke M, Rukavina T, Held TK, Cross AS, Marre R, Whitfield C.

Clin Diagn Lab Immunol. 1997 Sep;4(5):550-5.

29.

Effects of MICs and sub-MICs of antibiotics on production of capsular polysaccharide of Klebsiella pneumoniae.

Held TK, Adamczik C, Trautmann M, Cross AS.

Antimicrob Agents Chemother. 1995 May;39(5):1093-6.

30.

Malaria prophylaxis: identifying risk groups for non-compliance.

Held TK, Weinke T, Mansmann U, Trautmann M, Pohle HD.

Q J Med. 1994 Jan;87(1):17-22.

PMID:
8140213
31.

Malaria chemoprophylaxis.

Held TK, Weinke T, Trautmann M, Mansmann U, Pohle HD.

Lancet. 1993 Aug 21;342(8869):503. No abstract available.

PMID:
8102464
32.
33.

Ferritin as the earliest prognostic marker in a case of visceral leishmaniasis.

Held TK, Trautmann M, Poggensee U, Mravak S.

J Infect. 1991 Jul;23(1):103-4. No abstract available.

PMID:
1885908

Supplemental Content

Support Center